
COVID-19: Dis-chem defers dividen
Loading player...
Dis-Chem is hoping caution will prove to be the right medicine. The pharmacy group has decided to defer its annual dividend until it has a better sense of the full impact of Covid-19.
In a related industry, the day hospital market is feeling the pinch as elective surgeries have been put on hold.
Business Day TV spoke to Rui Morais, CFO of Dis-Chem for greater perspective on how the company is positioning itself in the current trading environment, while Gerhard van Emmenis, CEO of Advanced Health weighed in on the impact the pandemic is having on day hospitals.
In a related industry, the day hospital market is feeling the pinch as elective surgeries have been put on hold.
Business Day TV spoke to Rui Morais, CFO of Dis-Chem for greater perspective on how the company is positioning itself in the current trading environment, while Gerhard van Emmenis, CEO of Advanced Health weighed in on the impact the pandemic is having on day hospitals.





